• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性疼痛试验中的缺失数据处理

Missing data handling in chronic pain trials.

作者信息

Kim Yongman

机构信息

Food and Drug Administration, Silver Spring, Maryland, USA.

出版信息

J Biopharm Stat. 2011 Mar;21(2):311-25. doi: 10.1080/10543406.2011.550112.

DOI:10.1080/10543406.2011.550112
PMID:21391004
Abstract

In chronic pain trials, proper handling of missing data due to dropout is an important issue because the dropout rate is high and the study conclusion may depend on the method chosen. The intent-to-treat (ITT) principle usually requires imputations for missing data to include the dropouts as well as completers in the statistical analysis. However, a statistical analysis with imputation might lead to a misinterpretation of clinical data. In chronic pain trials, treatment-related dropouts are clinical outcomes themselves. For example, an early dropout due to toxicity usually indicates a treatment failure, as does a dropout due to lack of efficacy. Problems with traditional methods such as last observation carried forward (LOCF) or baseline observation carried forward (BOCF) are identified especially in the chronic pain setting. Alternative methods, such as continuous responder analysis and two-part model analysis, treating dropouts as clinical events, are introduced with an example of osteoarthritis clinical trial data.

摘要

在慢性疼痛试验中,由于脱落导致的缺失数据的妥善处理是一个重要问题,因为脱落率很高,且研究结论可能取决于所选择的方法。意向性分析(ITT)原则通常要求对缺失数据进行插补,以便在统计分析中纳入脱落者和完成者。然而,进行插补的统计分析可能会导致对临床数据的错误解读。在慢性疼痛试验中,与治疗相关的脱落本身就是临床结局。例如,因毒性导致的早期脱落通常表明治疗失败,因缺乏疗效导致的脱落也是如此。尤其在慢性疼痛背景下,已发现传统方法(如末次观察结转法(LOCF)或基线观察结转法(BOCF))存在问题。本文以骨关节炎临床试验数据为例,介绍了将脱落视为临床事件的替代方法,如连续反应者分析和两部分模型分析。

相似文献

1
Missing data handling in chronic pain trials.慢性疼痛试验中的缺失数据处理
J Biopharm Stat. 2011 Mar;21(2):311-25. doi: 10.1080/10543406.2011.550112.
2
An overview of practical approaches for handling missing data in clinical trials.临床试验中处理缺失数据的实用方法概述。
J Biopharm Stat. 2009 Nov;19(6):1055-73. doi: 10.1080/10543400903242795.
3
A bias correction in testing treatment efficacy under informative dropout in clinical trials.临床试验中信息性删失情况下检验治疗效果的偏差校正
J Biopharm Stat. 2009 Nov;19(6):980-1000. doi: 10.1080/10543400903242753.
4
Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates.在前后测试设计中,针对存在大量失访率的意向性分析的数据分析策略比较。
Psychiatry Res. 2008 Sep 30;160(3):335-45. doi: 10.1016/j.psychres.2007.08.005. Epub 2008 Aug 20.
5
A comparison of the random-effects pattern mixture model with last-observation-carried-forward (LOCF) analysis in longitudinal clinical trials with dropouts.在存在失访情况的纵向临床试验中,随机效应模式混合模型与末次观察值结转(LOCF)分析的比较。
J Biopharm Stat. 1998 Nov;8(4):545-63. doi: 10.1080/10543409808835259.
6
Comparisons of methods for analysis of repeated binary responses with missing data.对有缺失数据的重复二元反应分析方法的比较。
J Biopharm Stat. 2011 May;21(3):371-92. doi: 10.1080/10543401003687129.
7
Baseline observation carry forward: reasoning, properties, and practical issues.基线观察值结转:推理、性质及实际问题
J Biopharm Stat. 2009 Jul;19(4):672-84. doi: 10.1080/10543400902964118.
8
Intent-to-treat analysis for longitudinal studies with drop-outs.针对存在失访情况的纵向研究的意向性分析。
Biometrics. 1996 Dec;52(4):1324-33.
9
Last-observation-carried-forward imputation method in clinical efficacy trials: review of 352 antidepressant studies.末次观测结转(LOCF)推断法在临床疗效试验中的应用:352 项抗抑郁研究综述。
Pharmacotherapy. 2009 Dec;29(12):1408-16. doi: 10.1592/phco.29.12.1408.
10
Comparison of imputation and modelling methods in the analysis of a physical activity trial with missing outcomes.缺失结局的体力活动试验分析中插补法与建模方法的比较
Int J Epidemiol. 2005 Feb;34(1):89-99. doi: 10.1093/ije/dyh297. Epub 2004 Aug 27.

引用本文的文献

1
Cluster-Randomised Controlled Trial of At-Home Virtual Reality for People With Chronic Musculoskeletal Pain on the Waiting List.针对候诊名单上慢性肌肉骨骼疼痛患者的家庭虚拟现实集群随机对照试验。
Eur J Pain. 2025 Jul;29(6):e70073. doi: 10.1002/ejp.70073.
2
The Influence of Missing Data on Disabilities in Patients Treated with High-Dose Spinal Cord Stimulation: A Tipping Point Sensitivity Analysis.高剂量脊髓刺激治疗患者中缺失数据对残疾的影响:临界点敏感性分析
J Clin Med. 2021 Oct 24;10(21):4897. doi: 10.3390/jcm10214897.
3
IMPORTANCE trial: a provisional study-design of a single-center, phase II, double-blinded, placebo-controlled, randomized, 4-week study to compare the efficacy and safety of intranasal esketamine in chronic opioid refractory pain.
重要性试验:一项单中心、二期、双盲、安慰剂对照、随机、为期 4 周的研究的临时研究设计,旨在比较鼻内依他佐辛治疗慢性阿片类药物难治性疼痛的疗效和安全性。
F1000Res. 2021 Jan 22;10:42. doi: 10.12688/f1000research.27809.1. eCollection 2021.
4
Essential statistical principles of clinical trials of pain treatments.疼痛治疗临床试验的基本统计学原理。
Pain Rep. 2020 Dec 18;6(1):e863. doi: 10.1097/PR9.0000000000000863. eCollection 2021 Jan-Feb.
5
Mirogabalin in Japanese Patients with Renal Impairment and Pain Associated with Diabetic Peripheral Neuropathy or Post-Herpetic Neuralgia: A Phase III, Open-Label, 14-Week Study.米罗加巴林用于日本肾功能损害及伴有糖尿病性周围神经病变或带状疱疹后神经痛的疼痛患者:一项III期开放标签14周研究。
J Pain Res. 2020 Jul 17;13:1811-1821. doi: 10.2147/JPR.S255345. eCollection 2020.
6
Estimands and missing data in clinical trials of chronic pain treatments: advances in design and analysis.慢性疼痛治疗临床试验中的目标和缺失数据:设计和分析的进展。
Pain. 2020 Oct;161(10):2308-2320. doi: 10.1097/j.pain.0000000000001937.
7
Study adherence in a tDCS longitudinal clinical trial with people with spinal cord injury.脊髓损伤患者经颅直流电刺激纵向临床试验中的研究依从性。
Spinal Cord. 2018 May;56(5):502-508. doi: 10.1038/s41393-017-0023-5. Epub 2017 Dec 13.
8
Evaluation of a fixed-dose combination of benazepril and pimobendan in dogs with congestive heart failure: a randomized non-inferiority clinical trial.贝那普利与匹莫苯丹固定剂量复方制剂用于犬充血性心力衰竭的评估:一项随机非劣效性临床试验。
J Vet Sci. 2018 Jan 31;19(1):117-128. doi: 10.4142/jvs.2018.19.1.117.
9
Efficacy and safety of oral robenacoxib (tablet) for the treatment of pain associated with soft tissue surgery in client-owned dogs.口服罗贝考昔(片剂)治疗宠物犬软组织手术相关疼痛的疗效和安全性。
BMC Vet Res. 2017 Jun 26;13(1):197. doi: 10.1186/s12917-017-1100-x.
10
Efficacy and Safety of Injectable Robenacoxib for the Treatment of Pain Associated With Soft Tissue Surgery in Dogs.注射用罗贝考昔治疗犬软组织手术相关疼痛的有效性和安全性。
J Vet Intern Med. 2017 May;31(3):832-841. doi: 10.1111/jvim.14698.